DANAHER CORP (DHR)
US2358511028 - Common Stock
Danaher Reports Third Quarter 2024 Results
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended September 27, 2024. All results in this release...
Noteworthy Thursday Option Activity: DHR, NBR, VRT
Which S&P500 stocks are moving before the opening bell on Thursday?
Discover the top S&P500 movers in Thursday's pre-market session and stay informed about market dynamics.
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Wednesday.
Wednesday's session: top gainers and losers in the S&P500 index
Uncovering Noteworthy Technical Analysis Findings for DANAHER CORP (NYSE:DHR).
The technical analysis for DANAHER CORP (NYSE:DHR) is highly positive, with a rating of 8 out of 10, suggesting a potential breakout.
November 29th Options Now Available For Danaher (DHR)
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain.
Notable Thursday Option Activity: HAL, DLTR, DHR
November 8th Options Now Available For Danaher (DHR)
Danaher Schedules Third Quarter 2024 Earnings Conference Call
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the third quarter 2024 on Tuesday,...
Beckman Coulter and Scopio Labs Add World's First Digital Bone Marrow Imaging and Analysis to Long-Term Partnership
/PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions,...
Danaher Announces Quarterly Dividend
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.27 per share...
October 25th Options Now Available For Danaher (DHR)
Danaher Confirms Third Quarter and Full Year 2024 Guidance
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") confirmed its previously issued guidance for the third quarter and full year 2024 ahead of a...
Notable Friday Option Activity: DHR, HUT, MRNA
Danaher to Webcast Diagnostics Investor & Analyst Meeting in Washington, D.C.
/PRNewswire/ -- Danaher Corporation (NYSE: DHR) will host a live video webcast of its Diagnostics Investor and Analyst Meeting in Washington, D.C. on September...
September 27th Options Now Available For Danaher (DHR)